← Browse by Condition
Medical Condition

oligometastatic squamous cell carcinoma of the head and neck

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT05815927 Phase 3
Recruiting

Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer

Enrollment
200 pts
Location
Belgium, Italy, Spai...
Sponsor
European Organisation for Rese...
View Trial →